Clinical Trial Update: Durvalumab (MEDI4736) Plus Platinum-based Chemotherapy in Advanced LCNEC: a Pilot Phase II Study [Phase 2]

View source ↗

Summary

Pilot Phase II study evaluating durvalumab plus platinum-based chemotherapy in advanced LCNEC (large cell neuroendocrine carcinoma) patients who are treatment-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Neuroendocrine Carcinoma of the Lung

Drugs mentioned

• Durvalumab (durvalumab)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Elizabeth Dudnik | Conditions: Patients With Advanced Treatment Naive LCNEC | Phase 2 | Status: UNKNOWN